Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T-Cell Activation in the Heart and Promote Cardiac Dysfunction
- 19 January 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 143 (12) , 1242-1255
Abstract
Background: Despite the well-established association between T-cell–mediated inflammation and nonischemic heart failure, the specific mechanisms triggering T-cell activation during the progression of heart failure and the antigens involved are poorly understood. We hypothesized that myocardial oxidative stress induces the formation of isolevuglandin (IsoLG)–modified proteins that function as cardiac neoantigens to elicit CD4+ T-cell receptor (TCR) activation and promote heart failure. Methods: We used transverse aortic constriction in mice to trigger myocardial oxidative stress and T-cell infiltration. We profiled the TCR repertoire by mRNA sequencing of intramyocardial activated CD4+ T cells in Nur77 GFP reporter mice, which transiently express GFP on TCR engagement. We assessed the role of antigen presentation and TCR specificity in the development of cardiac dysfunction using antigen presentation–deficient MhcII −/− mice and TCR transgenic OTII mice that lack specificity for endogenous antigens. We detected IsoLG protein adducts in failing human hearts. We also evaluated the role of reactive oxygen species and IsoLGs in eliciting T-cell immune responses in vivo by treating mice with the antioxidant TEMPOL and the IsoLG scavenger 2-hydroxybenzylamine during transverse aortic constriction, and ex vivo in mechanistic studies of CD4+ T-cell proliferation in response to IsoLG-modified cardiac proteins. Results: We discovered that TCR antigen recognition increases in the left ventricle as cardiac dysfunction progresses and identified a limited repertoire of activated CD4+ T-cell clonotypes in the left ventricle. Antigen presentation of endogenous antigens was required to develop cardiac dysfunction because MhcII −/− mice reconstituted with CD4+ T cells and OTII mice immunized with their cognate antigen were protected from transverse aortic constriction–induced cardiac dysfunction despite the presence of left ventricle–infiltrated CD4+ T cells. Scavenging IsoLGs with 2-hydroxybenzylamine reduced TCR activation and prevented cardiac dysfunction. Mechanistically, cardiac pressure overload resulted in reactive oxygen species–dependent dendritic cell accumulation of IsoLG protein adducts, which induced robust CD4+ T-cell proliferation. Conclusions: Our study demonstrates an important role of reactive oxygen species–induced formation of IsoLG-modified cardiac neoantigens that lead to TCR-dependent CD4+ T-cell activation within the heart.Keywords
This publication has 32 references indexed in Scilit:
- Toll‐Like Receptor‐2 Mediates Adaptive Cardiac Hypertrophy in Response to Pressure Overload Through Interleukin‐1β Upregulation via Nuclear Factor κB ActivationJournal of the American Heart Association, 2013
- Vitamin E Supplementation and the Risk of Heart Failure in WomenCirculation: Heart Failure, 2012
- T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouseJournal of Experimental Medicine, 2011
- Modulation of Protein Function by Isoketals and Levuglandins2007
- Role of Oxidative Stress in Cardiac Hypertrophy and RemodelingHypertension, 2007
- Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and CancerJAMA, 2005
- CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86Nature Immunology, 2004
- Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91 phoxCirculation, 2004
- Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac HypertrophyCirculation Research, 2003
- Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trialsThe Lancet, 2003